Press Releases about Can-Fite Biopharma Ltd ADR
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240628278831/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240624268136/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240610723784/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240605024229/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240529561163/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240527479547/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240523651578/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240513153232/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20240509103593/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240506802750/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240425661063/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240415044511/en/2097948/22/Liver2.jpg)
![](https://mms.businesswire.com/media/20240403043294/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240328586605/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Can-Fite Reports 2023 Financial Results and Clinical Update
March 28, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240311582155/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240228950836/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240130659110/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20240129306975/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231220739293/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231218865060/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan
December 18, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231204860062/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231130873648/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231121112108/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231101858156/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231030418972/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231026204622/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20231009671086/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.